Linear Diagnostics is a cutting-edge brand specializing in next-generation near-patient diagnostics. With a focus on sexually transmitted infection (STI) management, our innovative technology, utilizing EXPAR and Linear Dichroism, delivers accurate results in under 15 minutes, providing rapid point-of-care testing. However, our solutions extend beyond STIs as our patented linear dichroism technology offers distinct advantages, including the ability to measure multiple targets simultaneously, making it applicable to a wide range of diagnostic applications.

At Linear Diagnostics, we strive to deliver enhanced diagnostic solutions through novel technology. Our goal is to improve patient outcomes and experiences by enabling immediate treatment of positive patients, decreasing onward transmission, lowering the risk of antibiotic resistance, reducing healthcare costs, and ultimately transforming the way infectious diseases are diagnosed and managed. With over 1 million new cases of STIs diagnosed daily and an estimated market size of over $30 billion, we are committed to addressing this global health challenge.

Trust Linear Diagnostics for rapid, accurate, and game-changing diagnostics